Next Article in Journal
Head and Neck Cancer: A Study on the Complex Relationship between QoL and Swallowing Function
Previous Article in Journal
Combining Novel Hormonal Therapies with a Poly (ADP-Ribose) Polymerase Inhibitor for Metastatic Castration-Resistant Prostate Cancer: Emerging Evidence
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 30
Issue 12
10.3390/curroncol30120752
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany

by
Smita George Thoduka
1,*,
Luka Flegar
2,
Christer Groeben
2,
Johannes Huber
2,
Nicole Eisenmenger
3,
Tobias Paulus
4,
Katharina Vogt
5,
Markus Luster
1 and
Nasreddin Abolmaali
4
1
Department of Nuclear Medicine, Philipps University of Marburg, 35043 Marburg, Germany
2
Department of Urology, Philipps University of Marburg, 35043 Marburg, Germany
3
Reimbursement Institute, 30354 Hürth, Germany
4
Department for Diagnostic and Interventional Radiology and Nuclear Medicine, St. Josef Hospital, Ruhr-University Bochum, 44791 Bochum, Germany
5
Department of Radiology and Interventional Radiology, University Hospital Freiburg, 79110 Breisgau, Germany
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2023, 30(12), 10325-10335; https://doi.org/10.3390/curroncol30120752
Submission received: 3 October 2023 / Revised: 30 November 2023 / Accepted: 4 December 2023 / Published: 5 December 2023
(This article belongs to the Topic Hepatobiliary and Pancreatic Diseases: Novel Strategies of Diagnosis and Treatments)
Browse Figures
Versions Notes

Abstract

The aim of this study was to investigate trends in selective internal radiation therapy (SIRT) for hepatocellular carcinoma (HCC), cholangiocarcinoma (CCC), and liver metastasis in Germany. We analyzed the nationwide German hospital billing database from 2006 to 2019 for the diagnosis of HCC, CCC or liver metastasis in combination with SIRT. For analyses of SIRT on the hospital level, we used the reimbursement.INFO tool based on German hospitals’ quality reports from 2008 to 2021. Linear regression analysis was performed to detect changes over time. We included a total of 14,165 SIRT procedures. The annual numbers increased from 99 in 2006 to 1605 in 2015 (p < 0.001; increase by 1521%), decreasing to 1175 cases in 2019 (p < 0.001). In 2008, 6 of 21 hospitals (28.6%) performed more than 20 SIRTs per year, which increased to 19 of 53 (35.8%) in 2021. The share of SIRT for HCC increased from 29.8% in 2006 to 44.7% in 2019 (p < 0.001) and for CCC from 0% in 2006 to 9.5% in 2019 (p < 0.001), while the share of SIRT for liver metastasis decreased from 70.2% in 2006 to 45.7% in 2019 (p < 0.001). In-hospital mortality was 0.2% after the SIRT procedure. Gastritis (2.7%), liver failure (0.4%), and sepsis (0.3%) were the most common in-hospital complications reported. We observed an increase in SIRT procedures in Germany, with the number of hospitals offering the procedure going up from 21 in 2008 to 53 in 2021. While the treatment of liver metastasis remains the most common indication, SIRT for HCC and CCC increased significantly over the last few years. The mortality and complication rates show that SIRT is a relatively safe procedure.
Keywords: SIRT; population-based; trends; hepatocellular carcinoma (HCC); cholangiocarcinoma (CCC); liver metastasis SIRT; population-based; trends; hepatocellular carcinoma (HCC); cholangiocarcinoma (CCC); liver metastasis

Share and Cite

MDPI and ACS Style

Thoduka, S.G.; Flegar, L.; Groeben, C.; Huber, J.; Eisenmenger, N.; Paulus, T.; Vogt, K.; Luster, M.; Abolmaali, N. Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Curr. Oncol. 2023, 30, 10325-10335. https://doi.org/10.3390/curroncol30120752

AMA Style

Thoduka SG, Flegar L, Groeben C, Huber J, Eisenmenger N, Paulus T, Vogt K, Luster M, Abolmaali N. Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Current Oncology. 2023; 30(12):10325-10335. https://doi.org/10.3390/curroncol30120752

Chicago/Turabian Style

Thoduka, Smita George, Luka Flegar, Christer Groeben, Johannes Huber, Nicole Eisenmenger, Tobias Paulus, Katharina Vogt, Markus Luster, and Nasreddin Abolmaali. 2023. "Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany" Current Oncology 30, no. 12: 10325-10335. https://doi.org/10.3390/curroncol30120752

APA Style

Thoduka, S. G., Flegar, L., Groeben, C., Huber, J., Eisenmenger, N., Paulus, T., Vogt, K., Luster, M., & Abolmaali, N. (2023). Trends in Selective Internal Radiation Therapy (SIRT) for Treating Hepatocellular Carcinoma, Cholangiocarcinoma, and Liver Metastasis: A Total Population Analysis from 2006 to 2021 in Germany. Current Oncology, 30(12), 10325-10335. https://doi.org/10.3390/curroncol30120752

Article Metrics

Back to TopTop